Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies

NCT07345780 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Donghua Zhang